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Abstract
Background: Various actions have been taken during the last decade to increase the number of organs from deceased
donors available for transplantation in Switzerland. This study provides an overview on key figures of the Swiss deceased
organ donation and transplant activity between 2008 and 2017. In addition, it puts the evolution of the Swiss donation
program’s efficiency in relation to the situation in the neighboring countries.
Methods: This study is an analysis of prospective registry data, covering the period from 1 January 2008 to 31 December
2017. It includes all actual deceased organ donors (ADD) in Switzerland. Donor data were extracted from the Swiss Organ
Allocation System. The “donor conversion index” (DCI) methodology and data was used for the comparison of donation
program efficiency in Switzerland, Germany, Austria, Italy and France.
Results: During the study period there were 1116 ADD in Switzerland. The number of ADD per year increased from 91
in 2008 to 145 in 2017 (+ 59%). The reintroduction of the donation after cardiocirculatory death (DCD) program in 2011
resulted in the growth of annual percentages of DCD donors, reaching a maximum of 27% in 2017. The total number of
organs transplanted from ADD was 3763 (3.4 ± 1.5 transplants per donor on average). Of these, 48% were kidneys
(n = 1814), 24% livers (n= 903), 12% lungs (n = 445), 9% hearts (n= 352) and 7% pancreata or pancreatic islets (n = 249).
The donation program efficiency assessment showed an increase of the Swiss DCI from 1.6% in 2008 to 2.7% in 2017
(+ 69%). The most prominent efficiency growth was observed between 2012 and 2017. Even though Swiss donation
efficiency increased during the study period, it remained below the DCI of the French and Austrian donation programs.
Conclusion: Swiss donation activity and efficiency grew during the last decade. The increased donation efficiency
suggests that measures implemented so far were effective. The lower efficiency of the Swiss donation program,
compared to the French and Austrian programs, may likely be explained by the lower consent rate in Switzerland.
This issue should be addressed in order to achieve the goal of more organs available for transplantation.
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Background
Various actions have been taken during the last decade
to improve the situation of deceased organ donation in
Switzerland. Swisstransplant, the Swiss National Founda-
tion for Organ Donation and Transplantation, and its
Comité National du Don d’Organes (CNDO) have im-
plemented a broad range of measures to increase the
number of organs available for transplantation in
Switzerland. In late 2011, the donation after cardiocircu-
latory death (DCD) program was reintroduced following
an initiative by Swisstransplant [1–3]. In addition, a na-
tional monitoring program of all patients who die in in-
tensive care units was developed and introduced by
Swisstransplant and the CNDO in 2011, and subse-
quently extended to patients who die in accident and
emergency departments [4, 5]. Since then, this prospect-
ive cohort study, called Swiss Monitoring of Potential
Donors (SwissPOD), assures that patients who may qual-
ify for organ and tissue donation are detected, and that
the next of kin are approached about organ donation in
compliance with the Swiss Transplantation Law [4–9].
In the framework of the national action plan “More
Organs for Transplantation”, launched in 2013 by the
Federal Office of Public Health (FOPH) and the cantons,
Swisstransplant and the CNDO were commissioned to
develop and implement further measures to advance de-
ceased organ donation in Switzerland [10]. These mea-
sures included the training of medical staff, analyzing
and optimizing processes and improving quality man-
agement and establishing appropriate structures and re-
sources [10–12]. The action taken so far resulted in a
notable increase of deceased organ donation since 2012
[13]. However, it seems that the federal action plan’s
main goal, a donation rate of at least 20 donors after
brain death (DBD) per million of population in 2018,
may not be achieved [10]. This means that the Swiss
DBD donation rate remains relatively low in inter-
national comparisons [14, 15]. More importantly, it also
means that organs donated for transplantation continue
to be a scarce resource in Switzerland.
The aim of this study was twofold: First, to give an
overview on key figures of the Swiss deceased organ do-
nation and transplant activity between 2008 and 2017.
Second, to compare the evolution of the donation effi-
ciency of the Swiss donation program to that of the
neighboring countries: Germany, Austria, Italy and
France. Finally, we discuss the current situation of organ
donation and transplantation in Switzerland in the con-
text of future challenges.
Methods
This study is an analysis of prospective registry data.
It covers the period from 1 January 2008 to 31
December 2017 and includes all deceased organ donors in
Switzerland. Patient data of all actual DBD donors and
DCD (since 1 September 2011) donors were extracted
from the Swiss Organ Allocation System (SOAS). Demo-
graphic data from the Federal Statistical Office was used
for the calculation of the donation rate per million of
population (pmp), based on the permanent resident popu-
lation as of 1 January of each year (data available until
2016) [16].
The primary outcome of the study was the number of
actual deceased donors (ADD) and basic donor charac-
teristics per year. Per definition, an ADD is a consenting,
eligible organ donor in whom an operative incision has
been made with the intent of organ recovery for the pur-
pose of transplantation [17]. The secondary outcome
was the number of transplants enabled from these do-
nors. The sub-analysis of the number of grafts trans-
planted per donor was limited to the following organ
types: heart, lung, liver, kidney, and pancreas or pancre-
atic islets. In cases where more than one graft from one
single organ was transplanted each graft was counted in-
dividually (this applies to left and right kidney, split
livers, and to left and right lung lobes). Also included in
the organ count were grafts from Swiss donors that were
transplanted abroad within the framework of inter-
national organ exchange. Excluded from the organ count
were transplants performed in Switzerland with grafts
offered by foreign organ procurement organizations
within the framework of international organ exchange,
e.g. for super urgent listed patients awaiting a liver graft.
The international comparison of deceased donation
program efficiency is based on the “donor conversion
index” (DCI) methodology and data [14]. The DCI was
developed in the framework of the Council of Europe’s
European Committee on Organ Transplantation
(CD-P-TO) by an international working group led by
Swisstransplant. The DCI indicates how many ADD re-
sulted from 100 deaths from a selection of causes associ-
ated with brain death, such as cerebrovascular accidents,
anoxic brain damage and trauma resulting from traffic
accidents [14, 17]. Mortality data was only available until
2015; therefore, 2016 and 2017 DCI values were calcu-
lated based on 2015 mortality data. The DCI is inter-
preted as follows: a DCI of 4% equals four ADD that
resulted from 100 fatalities from the selected causes of
death [14]. Some of the potential included in the DCI
calculation may consist of patients who would not qual-
ify for organ donation. For example, patients who are
not dying in intensive care units but in palliative care
units or patients in whom brain death diagnosis cannot
be performed within the required timeframe. However,
this is a general limitation of the DCI that equally ap-
plies to all countries included in our study.
Donor data for the year 2017 were retrieved from the
websites of Eurotransplant (Austria, Germany) and
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Centro Nazionale Trapianti (Italy) [18, 19]. These figures
represent utilized donors (deceased donors from whom
at least one organ was transplanted [17]), as no ADD
data was available. No donation data for 2017 was pub-
lished by the French Agence de la biomédecine at the
time of the writing of this article.
Results
During the 10-year study period, there were 1116 ADD.
The total number of ADD per year increased from 91 in
2008 to 145 in 2017 (+ 59%). While there was an overall
increase, inter-annual donation figures showed some
variance during the study period (Table 1). The reintro-
duction of the DCD program in late 2011 resulted in a
growing percentage of DCD donors, reaching its max-
imum annual proportion (27%, n = 39) of ADD (n = 145)
in 2017.
Patient characteristics of ADD in Switzerland between
2008 and 2017 are given in Table 1. The proportion of
female and male donors showed some inter-annual vari-
ances. Overall, 42% of donors were females (n = 473)
and 58% males (n = 643). The mean donor age showed
only minor variance during the 10 years analyzed, with
an overall mean donor age of 53 ± 18.2 years.
Donation and transplant activity
Table 2 shows annual donation and transplant activity
data. The donation rate (number of ADD per million of
population and year) was 12.0 pmp at the beginning of
the study period and reached 17.4 pmp at the end (14.0
pmp overall mean donation rate). The average DBD do-
nation activity was 12.6 pmp. It was highest in 2015
(15.4 pmp) and lowest in 2012 (11.2 pmp). The mean
DCD donation rate was 1.9 pmp (2011–2017), with the
lowest activity during the last four months of 2011 (0.4
pmp) and the highest in 2017 (4.7 pmp).
The overall average number of transplants enabled per
DBD donor was 3.5 ± 1.5, and 2.2 ± 1.1 grafts trans-
planted per DCD donor. The mean number of trans-
plants per DBD donor showed some inter-annual
variance, with slightly higher rates at the beginning of
the evaluation period. In DCD donors, the transplant
rate per donor increased until 2013 and showed a down-
ward trend thereafter.
The total number of hearts, lungs, livers, kidneys, and
pancreata or pancreatic islets transplanted during the
study period was 3763 from all ADD. Figures not included
in the table show that 94% (n = 3541) of transplants re-
sulted from DBD donors, and 6% (n = 222) from DCD do-
nors. Of all grafts transplanted (n = 3763), 48% were
kidneys (n = 1814), 24% livers (n = 903), 12% lungs (n =
445), 9% hearts (n = 352), and 7% pancreata or pancreatic
islets (n = 249). (The percentages per organ type shown in
the table represent the graft utilization rate.).
Table 2 also shows that the graft utilization rate (number
of grafts transplanted expressed as a percentage of the
number of ADD) varied considerably between the organ
types, as well as in some organ types over time. During the
entire study period, the graft utilization rate was highest for
kidney and liver (81% both), followed by lung (40%), heart
(35%; DBD only), and pancreas or pancreatic islets (22%).
Donation efficiency in comparison with neighboring
countries
A comparison of different countries’ donation rates pmp
has various limitations as discussed in detail in previous
publications [14, 20–26]. The major shortcoming of the do-
nation rate pmp is that it cannot give a proper account of
the potential for deceased donation. The donation rate is
calculated based on a country’s entire living population and
not on the actual mortality relevant to organ donation. An
evaluation of a donation program’s performance (i.e., its
conversion efficiency of the potential into donors), however,
needs to take place in the context of a realistic estimate of
the potential for deceased donation. If the potential is not
being accounted for, a comparison will be biased, as coun-
tries with a higher potential (mortality from relevant
causes) are likely to reach higher donation rates pmp, even
with a less efficient donation program. In this study, we
used DCI methodology and data [14] as a metric for the as-
sessment and comparison of donation efficiency.
Figure 1 shows the DCI evolution for Switzerland,
Germany, Austria, Italy, and France between 2008 and
2017. The DCI indicates how many ADD resulted from
100 deaths from various causes associated with brain
death, such as cerebrovascular accidents, anoxic brain
damage, trauma resulting from traffic accidents. Accord-
ing to the DCI, France and Austria had more efficient
donation programs than Switzerland in each year of the
study period. As in all countries (except for Germany),
the Swiss DCI increased during the last decade. At the
end of the evaluation period, the efficiency of the Swiss
donation program has increased by 69% compared with
the beginning (2.7% DCI in 2017 vs. 1.6% DCI in 2008).
Donation efficiency in Switzerland was relatively stable
(and similar to the efficiency of the German and Italian
donation programs) until 2011. Between 2012 and 2017,
the Swiss DCI increased most notably, showing a growth
of 50% (1.8% DCI in 2012 vs. 2.7% DCI in 2017). The ef-
ficiency of the Italian donation program also improved
during the evaluation period; however, the increase was
less pronounced. Germany was the only one among
Switzerland’s neighboring countries that showed a nega-
tive DCI trend over the evaluation period.
Discussion
Our analysis shows that both the deceased donation
activity and efficiency of the Swiss deceased organ
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donation program increased substantially during the last
decade. Despite the measures implemented so far, the ef-
ficiency of the Swiss donation program stays below the
French and Austrian programs. As a result of the im-
proved efficiency in the conversion of the potential into
donors, the Swiss program showed a moderately higher
performance than the Italian program at the end of the
study period.
Donation and transplant activity
The Swiss deceased donation activity (annual donation rate;
range 12.0–17.4 pmp, mean 14.0 pmp) during the study
period was lower than in Italy, France and Austria which
had annual donation rates > 20 pmp (Italy, Austria), and >
23 pmp (France) in each year between 2008 and 2015 [14].
Patient characteristics of Swiss donors during the dec-
ade preceding our study period showed a marked in-
crease in the mean age of donors [27]. In our study
period, the mean donor age remained roughly stable
(similar to the most recent historic data). Also, the mean
donor age of Swiss donors between 2008 and 2017 is
comparable to the mean age of French donors in recent
years [28]. In 2016 (latest ADD data published for the
neighboring countries), the average number of trans-
plants enabled per donor in Switzerland (3.3) was similar
to Germany (3.4) and Austria (3.1), and higher than in
France (2.7) and Italy (2.3) [15]. This means that in
countries with relatively low donation rates, a higher
transplant rate per donor may compensate, at least par-
tially, for the low donation activity. One should keep in
mind, however, that a more liberal use of extended cri-
teria donors (i.e., older donors and/or donors whose
medical conditions are considered suboptimal) may be
only suitable for selected subgroups of recipients, and
may impact the transplant outcome [29–32]. When
comparing average numbers of transplants enabled per
donor, it is also important to consider the fact that the
percentage of DCD donors in Switzerland (14% in 2016)
was markedly higher than in the other countries with a
DCD program (Italy, 1.4%; Austria, 2.8%; France, 4.8%)
[15]. Because in the countries included in the study, the
heart may be transplanted only from DBD donors, a lar-
ger proportion of DCD donors leads per se to a reduced
average number of transplants enabled in the totality of
DBD and DCD donors.
As DCD may be considered as supplementary to DBD,
the reintroduction of the Swiss DCD program has suc-
cessfully contributed to the increase of the number of
organs available for transplantation [3, 33]. As a matter
of fact, 222 grafts from DCD donors have been trans-
planted to patients on the Swiss waiting list since Sep-
tember 2011. This represents additional life-years and
quality of life gained by a considerable number of recipi-
ents. Because kidney transplants are cost-saving com-
pared with dialysis for patients with end-stage renal
failure, additional kidneys from DCD donors have also a
beneficial effect on health care expenditure [34].
Long-term outcomes of transplants with kidneys and
lungs from DCD donors seem to be similar compared
with grafts from DBD donors [35–42]. Liver transplant
outcomes from DCD donors have been reported as
sometimes inferior compared to DBD, especially after
prolonged warm ischemia time [35, 43–45].
Donation efficiency in comparison with neighboring
countries
The improved efficiency of the Swiss donation program
suggests that the measures implemented were effective.
Fig. 1 Donation efficiency evolution in Switzerland and neighboring countries, 2008–2017. * 2017 donation data for Austria, Italy and Germany
are utilized donors. The actual DCI of these donation programs may likely be 0.1–0.2 percentage points higher. 2008–2015 data retrieved from
[14]; sources of 2016–2017 data: [15, 18, 19, 71] and SOAS
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A considerable proportion of the DCI increase, however,
was due to the reintroduction of DCD. The DBD effi-
ciency also increased over time, but less pronouncedly.
Due to the relatively small absolute number of donors
per year in small countries, annual DCI variations may
occur (such as in 2016 in Switzerland or the see-sawing
of the Austrian DCI). Yet, the evolution of the Swiss
DCI shows a clear trend of increasing donation effi-
ciency since 2012.
When considering possible reasons for differences in
DCI between the countries, the consent rate (proportion
of patients and/or families consenting to organ dona-
tion) is one factor that has a major impact on the DCI.
Even though there is no internationally standardized way
to report consent rates, published data show important
differences between countries [5–8, 46, 47]. According
to 2012–2016 SwissPOD data, the overall consent rate
of patients who deceased in the participating Swiss in-
tensive care units was 43.5% [7]. This suggests that
roughly half of the donor potential was lost due to either
patients or their next of kin not consenting to organ dona-
tion. In contrast, recent data from France, Austria and
Italy (no data available for Germany) indicate that in these
countries, only approximately one third of the potential
was not converted because of patients or next of kin not
consenting to organ donation [15, 28]. If the consent rate
in Switzerland was similar to the approximately 70% con-
sent rate in France, Austria and Italy, the 2017 Swiss DCI
would be estimated at about 3.8% (2.7% divided by 0.5 and
multiplied by 0.7). Therefore, improving the consent rate
in Switzerland should result in a significant additional effi-
ciency increase of the Swiss donation program.
Evaluation of the current situation and outlook
In comparison with the neighboring countries and as
discussed above, the performance of the Swiss organ do-
nation and transplant program can be considered equal
or slightly better, as the average number of transplants
enabled per donor is similar to figures in Germany and
Austria, and higher than in France and Italy. The rela-
tively high number of transplants per donor contributes
substantially to the overall performance of the Swiss do-
nation program as it ensures an optimized use of the
limited donor pool.
One factor that clearly has a negative impact on the
donation activity and efficiency in Switzerland is the low
consent rate which is in contrast to the largely positive
attitude towards organ donation and transplantation
among the Swiss population [48–51]. Under the assump-
tion that the consent policy (explicit consent in
Switzerland and Germany, presumed consent in France,
Austria, and Italy) may have an impact on the consent
rate, it seems appropriate to consider changing the Swiss
policy in order to achieve the Federal action plan’s goal
of a refusal rate below 40% [10, 52]. The fact that the
consent rate in Switzerland has been roughly stable dur-
ing the study period indicates, however, that the growth
in efficiency may have resulted, at least to some degree,
from the measures implemented. Naturally, there is no
guarantee that a change in the system to presumed con-
sent in Switzerland would per se lead to an increased
rate of donors. Previous studies have pointed out that
awareness of the consent policy may play an important
role, and that changing the policy to presumed consent
requires adequate and continuous information of the
population [53–57]. Efforts in Switzerland during the
last decade have led to an efficient organ donation
process, and the consent rate remains the action area
with the most potential for a growth in the numbers of
donors.
Action areas of the action plan included the training
of healthcare professionals, the implementation of stan-
dardized processes and quality management, as well as
optimizing structures and allocating resources in the
hospitals [12, 58]. Swisstransplant and the CNDO were
commissioned by the FOPH and the cantons to accom-
plish these tasks.
The training of health care professionals has been
standardized and integrated in a newly created blended
learning program, established in 2015. The blended
learning program consists of ten e-learning modules,
and two face-to-face courses (“communication with next
of kin” and “medicine and quality in the donation
process”). Since its introduction, roughly one thousand
health care professionals have been enrolled in the pro-
gram. Hospital staff in charge with tasks related to organ
donation (the 150 local organ and tissue donation coor-
dinators) are required to complete the program and pass
the final exam within two years.
As an additional measure and since mid-2016, ear-
marked funds are being allocated to the local organ and
tissue donation coordinators. The allocation of ear-
marked funds has been a crucial step in the optimization
of the donation process. First, because these funds rec-
ompense defined percentages of coordinators’ working
time. Second and related, it is bound to enhanced ac-
countability concerning the specific tasks of the coordi-
nators. All hospitals with an accredited intensive care
unit are contractually obliged to designate a local organ
and tissue donation coordinator. To ensure a 24/7 dona-
tion coordination, the hospitals are clustered into dona-
tion networks, with each network having an on-call
service for donation coordination.
The optimization of structures and processes included,
among others, the involvement of accident and emer-
gency departments as well as paramedics, and the on-
going training of staff. While the action plan mainly
focused on optimizing the prerequisites for donation,
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one should bear in mind that there are other areas
where there may be additional potential for improve-
ment. For example, in donor management, procurement
and ex-vivo conditioning [59–62], or in the prevention
and treatment of diseases leading to terminal organ fail-
ure which could result in less patients who need to be
waitlisted for an organ transplantation [63–65].
Finally, an evaluation of the performance of the Swiss
organ donation and transplant program should take into
account that its ultimate goal is to enable a maximum of
transplants with a successful outcome. Outcome data for
transplant recipients in Switzerland are generally similar
or slightly better than the results reported in large inter-
national registries [66–69]. In view of the high average
number of organs transplanted per donor, and the rela-
tively high mean donor age (e.g., compared with US data
[70]), this is an excellent result in terms of quality of
care provided by the Swiss transplant centers.
Study strengths and limitations
Our study has several strengths and limitations. We con-
sider it the main strength that it provides key figures on the
evolution of the Swiss organ donation and transplant pro-
gram during the last decade. These data, in combination
with the assessment of the donation efficiency, should allow
the reader to gain a general overview on the performance
of the Swiss organ donation program. It also provides the
context for a comparison with the performance of the
donation programs in the neighboring countries.
Limitations of the DCI include that the mortality from
the selected causes allows only for an approximation of
the potential, and that international mortality data was
only available until 2015 (for a detailed discussion of the
DCI’s limitations see [14]). The 2016 and 2017 DCI values
of all countries included in our study are based on the
latest mortality data available (2015). The 2017 DCI values
of Austria, Italy, and Germany were calculated based on
utilized donors instead of ADD, as at the time of the
writing of this paper and to the best of our knowledge,
ADD data had not yet been published. This may lead to a
slightly underestimated DCI for these donation programs
in 2017. A final word of caution should be given regarding
the international comparability of consent rates. Due to
non-standardized modalities of consent rate reporting, the
data may not be completely comparable.
Conclusions
Even though the Swiss donation activity and efficiency
have been substantially improved during the last decade, it
remains below the French and Austrian donation rates
and DCI. This may be explained, at least in part, to the
considerably lower consent rate in Switzerland. The
increased donation efficiency in Switzerland suggests that
the measures implemented so far (allocation of earmarked
funds to local donation coordinators, optimized struc-
tures, training of healthcare professionals) have been
effective. In view of the fact that the consent rate has been
roughly stable at a low level, the Swiss intensive care units
were able to increase the performance considerably in
terms of donor detection and referral. The most important
factor that negatively impacts the donation activity and
efficiency is the high percentage of family refusals. This
issue needs to be addressed in order to achieve the goal of
more organs available for transplantation.
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